Study identifier:SD-004-0768
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Investigation of safety and efficacy of budesonide inhalation suspension in the long-term use in Japanese children with bronchial asthma (open long-term extension study following study SD-004-0765
asthma
Phase 3
No
Pulmicort (budesonide) Respules
All
54
Interventional
13 Months - 65 Months
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
No locations available
Arms | Assigned Interventions |
---|